Cargando…
Loss-of-function genetic diseases and the concept of pharmaceutical targets
The biomedical world relies heavily on the definition of pharmaceutical targets as an essential step in the drug design process. It is therefore tempting to apply this model to genetic diseases as well. However, whereas the model applies well to gain-of-function genetic diseases, it is less suited t...
Autor principal: | Ségalat, Laurent |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1936415/ https://www.ncbi.nlm.nih.gov/pubmed/17674486 http://dx.doi.org/10.1186/1750-1172-2-30 |
Ejemplares similares
-
Taking the lead from our colleagues in medical education: the use of images of the in-vivo setting in teaching concepts of pharmaceutical science
por: Curley, Louise E., et al.
Publicado: (2017) -
The Pharmaceutical Sciences in 2020: Report of a Conference Organized by the Board of Pharmaceutical Sciences of the International Pharmaceutical Federation (FIP)
por: Shah, Vinod P., et al.
Publicado: (2010) -
Pharmaceutical Policy Part 2 Pharmaceutical engagement and policy development: a framework for influence
por: Morrow, Norman C
Publicado: (2015) -
The pharmaceutical death-ride of dihydroartemisinin
por: Jansen, Frans Herwig
Publicado: (2010) -
Myxobacteria: natural pharmaceutical factories
por: Diez, Juana, et al.
Publicado: (2012)